<p>HNGC-2 cells were treated for 24 h with lomustine, carmustine, UCN-01, oxaliplatin, temozolomide, and tamoxifen (TAM) and cell viability was assessed by MTT assay. The cell viability of vehicle control cells was assumed as 100%. The data represents the mean ± SE (n = 3). * p< 0.01, comparison between vehicle control and treated cells.</p
<p>(<b>A</b>)–(<b>C</b>) MTT assay. (<b>A</b>) HUVECs were treated with 10–500 μM NaHS for 6 hours. ...
<p>PRB23 cells were treated with vehicle, 100 nM R5020, 1 uM MK-2206, or a combination of MK-2206+R5...
<p>L929 cells treated with 0.1–10 µM etoposide (ETO) for 24 h. <b>A.</b> MTS analysis show a dose-de...
<p>Primary GBM (G1) cells were treated with lomustine, carmustine, UCN-01, oxaliplatin, temozolomide...
<p>Ht-29 cells were treated with increasing concentrations of oxaliplatin (1–300 µM) in the presence...
<p>(A) Cytotoxic activity of compounds <b>1</b>, <b>2</b>, and <b>5</b> against cancer cells. The in...
<p>Cells were treated for 24h with compounds A13 (A), H12 (B), or with classical drugs staurosporine...
<p>Cells were treated with vehicle (Untreated Control), indicated doses of Cisplatin, various CFMs, ...
<p>U937 cell were exposed to 10 µg/mL of LPS for 24 h and cell viability was assessed by MTT assay. ...
<p><b>A</b>) The 4T-1 cells were treated with oHSV1 or oHSV2 at the indicated MOIs for the indicated...
<p>Representative images of (A) U87-MG and U–SC, and (B) L0627 morphology after 48 h treatment with ...
The primary cells HUVEC were treated with indicated concentrations of compounds for 72 h, then cell ...
<p>After the treatments and incubation, alterations in cell viability were measured by the MTT assay...
<p>Normal (HaCaT) and tumor cells (HeLa, T98G and U118)were treated with different TMZ concentration...
<p>A, Cytotoxic effects of DOX alone and DOX+LMB on cell viability of A549 cells as determined by th...
<p>(<b>A</b>)–(<b>C</b>) MTT assay. (<b>A</b>) HUVECs were treated with 10–500 μM NaHS for 6 hours. ...
<p>PRB23 cells were treated with vehicle, 100 nM R5020, 1 uM MK-2206, or a combination of MK-2206+R5...
<p>L929 cells treated with 0.1–10 µM etoposide (ETO) for 24 h. <b>A.</b> MTS analysis show a dose-de...
<p>Primary GBM (G1) cells were treated with lomustine, carmustine, UCN-01, oxaliplatin, temozolomide...
<p>Ht-29 cells were treated with increasing concentrations of oxaliplatin (1–300 µM) in the presence...
<p>(A) Cytotoxic activity of compounds <b>1</b>, <b>2</b>, and <b>5</b> against cancer cells. The in...
<p>Cells were treated for 24h with compounds A13 (A), H12 (B), or with classical drugs staurosporine...
<p>Cells were treated with vehicle (Untreated Control), indicated doses of Cisplatin, various CFMs, ...
<p>U937 cell were exposed to 10 µg/mL of LPS for 24 h and cell viability was assessed by MTT assay. ...
<p><b>A</b>) The 4T-1 cells were treated with oHSV1 or oHSV2 at the indicated MOIs for the indicated...
<p>Representative images of (A) U87-MG and U–SC, and (B) L0627 morphology after 48 h treatment with ...
The primary cells HUVEC were treated with indicated concentrations of compounds for 72 h, then cell ...
<p>After the treatments and incubation, alterations in cell viability were measured by the MTT assay...
<p>Normal (HaCaT) and tumor cells (HeLa, T98G and U118)were treated with different TMZ concentration...
<p>A, Cytotoxic effects of DOX alone and DOX+LMB on cell viability of A549 cells as determined by th...
<p>(<b>A</b>)–(<b>C</b>) MTT assay. (<b>A</b>) HUVECs were treated with 10–500 μM NaHS for 6 hours. ...
<p>PRB23 cells were treated with vehicle, 100 nM R5020, 1 uM MK-2206, or a combination of MK-2206+R5...
<p>L929 cells treated with 0.1–10 µM etoposide (ETO) for 24 h. <b>A.</b> MTS analysis show a dose-de...